418 related articles for article (PubMed ID: 25145434)
1. Immunotherapy in pediatric malignancies: current status and future perspectives.
Capitini CM; Otto M; DeSantes KB; Sondel PM
Future Oncol; 2014; 10(9):1659-78. PubMed ID: 25145434
[TBL] [Abstract][Full Text] [Related]
2. Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.
Huang MA; Krishnadas DK; Lucas KG
J Immunol Res; 2015; 2015():675269. PubMed ID: 26587548
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of childhood cancer: from biologic understanding to clinical application.
Wayne AS; Capitini CM; Mackall CL
Curr Opin Pediatr; 2010 Feb; 22(1):2-11. PubMed ID: 19952749
[TBL] [Abstract][Full Text] [Related]
4. [Role of Immunotherapy in Pediatric Oncology].
Bajčiová V
Klin Onkol; 2015; 28 Suppl 4():4S38-43. PubMed ID: 26647887
[TBL] [Abstract][Full Text] [Related]
5. Immune-based therapeutics for pediatric cancer.
Capitini CM; Mackall CL; Wayne AS
Expert Opin Biol Ther; 2010 Feb; 10(2):163-78. PubMed ID: 19947897
[TBL] [Abstract][Full Text] [Related]
6. Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.
Capitini CM; Cooper LJ; Egeler RM; Handgretinger R; Locatelli F; Sondel PM; Mackall CL
J Pediatr Hematol Oncol; 2009 Apr; 31(4):227-44. PubMed ID: 19346873
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapies for pediatric cancer: current landscape and future perspectives.
Hutzen B; Paudel SN; Naeimi Kararoudi M; Cassady KA; Lee DA; Cripe TP
Cancer Metastasis Rev; 2019 Dec; 38(4):573-594. PubMed ID: 31828566
[TBL] [Abstract][Full Text] [Related]
8. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
Fry TJ; Lankester AC
Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319
[TBL] [Abstract][Full Text] [Related]
9. Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".
Capitini CM; Gottschalk S; Brenner M; Cooper LJ; Handgretinger R; Mackall CL
Pediatr Hematol Oncol; 2011 Sep; 28(6):459-60. PubMed ID: 21854215
[TBL] [Abstract][Full Text] [Related]
10. Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology.
Orentas RJ; Mackall CL
Crit Rev Oncog; 2015; 20(3-4):315-27. PubMed ID: 26349422
[TBL] [Abstract][Full Text] [Related]
11. Current status and future prospects of peptide-based cancer vaccines.
Wada S; Yada E; Ohtake J; Fujimoto Y; Uchiyama H; Yoshida S; Sasada T
Immunotherapy; 2016 Nov; 8(11):1321-1333. PubMed ID: 27993087
[TBL] [Abstract][Full Text] [Related]
12. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Pasqualini C; Rialland F; Valteau-Couanet D; Michon J; Minard-Colin V
Bull Cancer; 2018 Dec; 105 Suppl 1():S68-S79. PubMed ID: 30595201
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
[TBL] [Abstract][Full Text] [Related]
15. Promising Immuno-Oncology Options for the Future: Cellular Therapies and Personalized Cancer Vaccines.
Solomon BJ; Beavis PA; Darcy PK
Am Soc Clin Oncol Educ Book; 2020 May; 40():1-6. PubMed ID: 32412805
[TBL] [Abstract][Full Text] [Related]
16. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.
Lohmueller J; Finn OJ
Pharmacol Ther; 2017 Oct; 178():31-47. PubMed ID: 28322974
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of immunotherapy for childhood cancers.
Handgretinger R; Schlegel P
Chin Clin Oncol; 2018 Apr; 7(2):14. PubMed ID: 29764159
[TBL] [Abstract][Full Text] [Related]
18. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for pediatric cancer.
Grupp SA; Verneris M; Sondel PM; Cooper LJ
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):33-43. PubMed ID: 18162219
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapies, their safety and toxicity.
Alatrash G; Jakher H; Stafford PD; Mittendorf EA
Expert Opin Drug Saf; 2013 Sep; 12(5):631-45. PubMed ID: 23668362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
